Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Joel Lewis files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 10X Fund, L.P. - $2.43M of GALT open-market activity in the last 12 months
- Khurram Jamil - $1.44M of GALT open-market activity in the last 12 months
- Jack W. Callicutt - $944K of GALT open-market activity in the last 12 months
- Harold H. Shlevin - $501K of GALT open-market activity in the last 12 months
- Kevin D. Freeman - $20K of GALT open-market activity in the last 12 months
- Kary Eldred - $3K of GALT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Joel Lewis?
Joel Lewis is a corporate insider, tracked as President and CEO of GALECTIN THERAPEUTICS INC (GALT). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Joel Lewis last file a Form 4?
The most recent primary Form 4 on record is dated 22 January 2026, one of 11 filings going back to 2024.
Has Joel Lewis been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($759K) across all tracked filings.
Where can I see all of Joel Lewis's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Joel Lewis and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
